Advemto Ltd. reposted this
We’re thrilled to have completed the first close of our Seed raise, with Movac Emerge Fund 4 leading the round, supported by NZ Growth Capital Partners, K1W1 LIMITED, and Icehouse Ventures. Advemto’s unique optical technology could be as revolutionary for hi-plex biomarker mapping as low-cost DNA sequencing was for genomics. Pharmaceuticals companies, clinical diagnostics labs and research labs rely on fluorescent labels to map biomarkers associated with disease and treatments. But currently, significant time and money is wasted on iterative panel design and low throughput analysis, because current optical detectors cannot sufficiently distinguish or quantify mixtures of fluorescent labels. With this Seed investment, Advemto will build a new generation flow cytometer that incorporates its 2D barcode reader – making it possible to resolve panels of fluorescent labels, instantly, precisely, and quantitatively. The team couldn’t be more excited to be opening this next chapter in life science tools, and we are grateful to many people who have supported our journey so far Kylie Price, Cather Simpson, Andrew Chen, Kevin Sheehy, Matt Trau, Nick Wilson, Andrew Coy, Wellington UniVentures, Daniel Batten, James Cameron, Quidnet Ventures, Booster NZ, Matū Group, SIP Innovation, The MacDiarmid Institute, and many many others! And stay tuned for more investment announcements on our rolling close........